• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Ibex Medical Analytics

Ibex wins CE mark for AI-powered gastric cancer detection tech

June 15, 2022 By Sean Whooley

Ibex Medical Analytics announced today that it received CE mark approval for its Galen gastric cancer detection solution. Tel Aviv, Israel-based Ibex uses artificial intelligence (AI) and machine learning technology to power its Galen platform for cancer diagnostics based on hundreds of thousands of image samples scanned from biopsy slides through digital pathology. Galen won […]

Filed Under: Diagnostics, Genomics/Molecular Diagnostics, Health Technology, Oncology, Software / IT Tagged With: CE Mark, Ibex Medical Analytics

Ibex appoints new CMO, moves CEO to Boston to lead U.S. expansion

September 14, 2021 By Sean Whooley

Ibex Medical Analytics announced today that it appointed Dr. Douglas Clark as its new chief medical officer. In addition to appointing Clark to its executive team, Ibex announced that co-founder & CEO Joseph Mossel will relocate to the U.S. to lead its North American expansion efforts from its Boston headquarters. Clark previously served as CMO […]

Filed Under: Business/Financial News, Diagnostics, Featured, Oncology Tagged With: Ibex Medical Analytics, Personnel Moves

Ibex AI-enabled breast cancer diagnostic lands CE mark

May 26, 2021 By Sean Whooley

Ibex Medical Analytics announced today that it received CE mark approval for its Galen AI-based breast cancer diagnostic platform. Tel Aviv, Israel–based Ibex’s Galen platform uses AI and machine learning technology based on hundreds of thousands of image samples scanned from biopsy slides through digital pathology, according to a news release. Galen previously won CE […]

Filed Under: Diagnostics, Featured, Health Technology, Imaging, Mammography, Oncology, Regulatory/Compliance, Software / IT, Women's Health Tagged With: Breast Cancer, CE Mark, Ibex Medical Analytics

Ibex wins CE Mark for AI-powered cancer detection software

February 27, 2020 By Sean Whooley

Ibex Medical Analytics announced today that it won CE Mark approval for its artificial intelligence-powered Galen Prostate software for identifying suspected cancer on prostate core needle biopsies. Tel Aviv-based Ibex touts its Galen prostate solution as the first-ever AI-based software for cancer detection used in routine clinical practice, and it is already deployed in pathology […]

Filed Under: Featured, Health Technology, Men's Health, Oncology, Regulatory/Compliance, Software / IT Tagged With: AI, artificial intelligence, CE Mark, Ibex Medical Analytics

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS